Pharmaceutical company Insmed is taking Wall Street by surprise today, falling to $66.29 and marking a -7.0% change compared ...

Boston Scientific expects the acquisition to have a positive impact on its future earnings. Specifically, the company ...

Cytokinetics sank -8.2% this morning, compared to the S&P 500's day change of -1.0%. Today's losers may turn out to be ...

The cash flow from operating activities also experienced a decrease, with cash generated from operating activities declining ...

Thermo Fisher Scientific stock is trading -21.47% below its average target price of $653.35 after dropping -3.7% during today ...

Gladstone Commercial Corporation is a real estate investment trust ("REIT") focused on acquiring, owning, and operating net ...

AT&T shares rose 1.9% this morning to a price of $22.68. The stock is still trading within range of its average target price ...

Following Mr. Brubaker’s departure, Michael LiCalsi, the company’s General Counsel and Secretary, will assume certain ...

The notes will be senior, unsecured obligations of Upstart and will bear interest payable semi-annually in arrears. They will ...

PureCycle Technologies, Inc. has recently released its 10-Q report, providing a comprehensive overview of the company's ...

David Eslick, Chairman and CEO of Marsh McLennan Agency, highlighted the potential for enhancing client-centric capabilities ...

CoStar's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 3.5%.